Form 4: Vita Coco CEO Sells Shares Under 10b5-1 Plan

Vita Coco's CEO, Martin Roper, sold a total of 40,000 shares of common stock through a pre-arranged 10b5-1 trading plan, with some shares sold directly and others through family trusts.

Summary

• Martin Roper, the CEO of Vita Coco Company, Inc., executed multiple sales of common stock on November 20 and 21, 2024.
• A total of 40,000 shares were sold, with 10,000 shares sold directly by Mr. Roper and 30,000 shares sold indirectly through family trusts.
• The sales were conducted under a pre-arranged Rule 10b5-1 trading plan.
• The direct sales were executed at weighted average prices of $35.397 and $36.647 per share.
• Indirect sales through family trusts were executed at weighted average prices ranging from $35.411 to $36.634 per share.
• The family trusts involved are the Christopher G. Roper Exempt Family Trust, the Peter S. Roper Exempt Family Trust, and the Thomas L. Roper Exempt Family Trust.
• Mr. Roper also holds various non-qualified stock options with different vesting schedules and exercise prices.

Sentiment

Score: 5

Explanation: The document reflects a routine transaction under a pre-arranged plan, with no indication of positive or negative sentiment. It is a neutral event.

Risks

• The sale of shares by the CEO could be perceived negatively by the market, potentially impacting the stock price.
• The use of a 10b5-1 trading plan suggests that the sales were pre-planned and not necessarily indicative of a change in the CEO's outlook on the company.

Industry Context

Executive stock sales are a common occurrence, and the use of a 10b5-1 plan is a standard practice to avoid accusations of insider trading. The sales do not necessarily indicate a negative outlook on the company's future.

Comparison to Industry Standards

• Executive stock sales are a common practice across publicly traded companies, often executed through pre-arranged 10b5-1 trading plans.
• The volume of shares sold by Martin Roper is not unusual for a CEO of a company of Vita Coco's size.
• Comparable companies often see similar filings from their executives, indicating routine portfolio management rather than a change in company outlook.

Stakeholder Impact

• The stock sales could potentially cause a slight decrease in the share price due to increased supply, but the impact is likely to be minimal given the pre-planned nature of the sales.
• The sales do not directly impact employees, customers, or suppliers.

Key Dates

Keywords

Vita Coco, Martin Roper, stock sale, 10b5-1 plan, insider trading, executive, common stock, family trust, stock options